Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: The CardioOrmocheck study

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 6, 2009, Pages 762-768

  Prontera, Concetta ^a   Zaninotto, Martina ^c   Giovannini, Stefania ^a   Zucchelli, Gian Carlo ^a   Pilo, Alessandro ^a   Sciacovelli, Laura ^d   Plebani, Mario ^c   Clerico, Aldo ^a,b,e  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d Biomedical Research Center of Castelfranco Veneto   (Italy)

^e Laboratory of Cardiovascular Endocrinology and Cell Biology   (Italy)

Author keywords

Brain natriuretic peptide (BNP); N terminal part of the propeptide of BNP (NT proBNP); Natriuretic peptides; Quality control

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; EDETIC ACID;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; FREEZE DRYING; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; QUALITY CONTROL;

CASE-CONTROL STUDIES; HEART DISEASES; HUMANS; IMMUNOASSAY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 67650637716     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.153     Document Type: Article

References (18)

1. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006;290: H17-29.
2. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review. Clin Chem 2004;50:33-50.
3. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164:1978-84.
4. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 2007;53:813-22.
5. Ewald B, Ewald D, Thakkinstian A, Attia J. Meta-analysis of B type natriuretic peptide and N-terminal pro B natri-uretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction. Intern Med J 2008;38:101-13.
6. Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007;116:e99-109.
7. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416.
8. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.
9. Clerico A, Del Ry S, Giannessi D. Measurement of natri-uretic cardiac hormones (ANP, BNP, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 2000;46:1529-34.
10. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AHB, Tate J, et al. On behalf of the committee on standardization of markers of cardiac damage of the IFCC. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005;51:486-93.
11. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, Cannon CP, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 2007;116:e95-8.
12. Vittorini S, Prontera T, Zucchelli GC, Clerico A. Cardiac natriuretic hormones: methodological aspects. Immuno-Analyse Biol Spec 2007;22:209-72.
13. Siemens Technical Bulletin. Dimension clinical chemistry system: heterogeneous immunoassay module. REF.RF423A, 2008.
14. Clerico A, Prontera C, Emdin M, Passino C, Storti S, Poletti R, et al. Analytical performance and diagnostic accuracy of immunometricassays for the measurement of plasma BNP and NT-proBNP concentrations. Clin Chem 2005;51:445-7.
15. Clerico A, Carlo Zucchelli G, Pilo A, Passino C, Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med 2006;44:366-78.
16. Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N-terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004; 15:365-8.
17. Jarausch J, Garcia-Beltran L, Gremmelr B, Hensel-Wiegel K, Luthe H, Meisel S, et al. Multicentre evaluation of the second generation Elecsys NT-proBNP assay. (Abstract B-137) Clin Chem 2008;54(Suppl 6):A93.
18. Prontera C, Zucchelli GC, Vittorini S, Storti S, Emdin M, Clerico A. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP. Clin Chim Acta 2009;400:70-3.